Russell Investments Group
ICPT

Russell Investments Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Russell Investments Group’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-61,075
Closed -$675K – 3660
2023
Q2 		$675K Sell
61,075
-12,731
-17% -$177K ﹤0.01% 2112
2023
Q1 		$991K Buy
73,806
+12,138
+20% +$210K ﹤0.01% 1965
2022
Q4 		$763K Buy
61,668
+7,065
+13% +$100K ﹤0.01% 2111
2022
Q3 		$760K Buy
54,603
+5,717
+12% +$92.1K ﹤0.01% 2060
2022
Q2 		$674K Sell
48,886
-4,499
-8% -$72K ﹤0.01% 2136
2022
Q1 		$867K Sell
53,385
-15,460
-22% -$242K ﹤0.01% 2021
2021
Q4 		$1.12M Sell
68,845
-8,192
-11% -$138K ﹤0.01% 2089
2021
Q3 		$1.14M Sell
77,037
-2,446
-3% -$39.1K ﹤0.01% 2132
2021
Q2 		$1.59M Buy
79,483
+29,277
+58% +$580K ﹤0.01% 2054
2021
Q1 		$1.16M Sell
50,206
-71,235
-59% -$1.99M ﹤0.01% 2185
2020
Q4 		$3M Sell
121,441
-62,772
-34% -$2.08M 0.01% 1536
2020
Q3 		$7.64M Buy
184,213
+142,310
+340% +$6.54M 0.02% 910
2020
Q2 		$2.01M Buy
41,903
+22,043
+111% +$1.7M ﹤0.01% 1635
2020
Q1 		$1.25M Sell
19,860
-701
-3% -$63K ﹤0.01% 1735
2019
Q4 		$2.55M Buy
20,561
+2,407
+13% +$215K ﹤0.01% 1590
2019
Q3 		$1.2M Buy
+18,154
New +$1.22M ﹤0.01% 1923
2018
Q1 		– Sell
-30
Closed -$2K – 3029
2017
Q4 		$2K Hold
30
– – ﹤0.01% 2945
2017
Q3 		$2K Sell
30
-14,062
-100% -$1.51M ﹤0.01% 2927
2017
Q2 		$1.71M Sell
14,092
-591
-4% -$68.5K ﹤0.01% 1821
2017
Q1 		$1.66M Buy
14,683
+1,600
+12% +$187K ﹤0.01% 1837
2016
Q4 		$1.43M Buy
+13,083
New +$1.56M ﹤0.01% 1996

Other funds holding ICPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Russell Investments Group's ICPT Position: Q3 2023 in Review

Russell Investments Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2023, closing a stake of 61,075 shares — an estimated $675K sold.

Russell Investments Group first reported a position in ICPT in Q4 2016 and held it in 21 quarters. The position peaked at $7.64M in Q3 2020. 146 funds tracked by Wall St. Rank hold ICPT as of Q3 2023.

  • Russell Investments Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Russell Investments Group sold 61,075 Intercept Pharmaceuticals, Inc. shares in Q3 2023, an estimated $675K.
  • Russell Investments Group first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2016 and held it in 21 quarters.
  • Russell Investments Group's Intercept Pharmaceuticals, Inc. position peaked at $7.64M in Q3 2020.
  • 146 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2023.

Based on Russell Investments Group's 13F filing for Q3 2023, filed 13 Nov 2023.